When does the Zoloft (sertraline) patent expire?
Zoloft’s original patent protection in the U.S. has long since passed, and the drug has been available as a generic for years. What typically matters now is when specific later patents (for new formulations, dosing methods, or line extensions) expire, if any remain active in a given country.
If you’re trying to find the exact expiration date for a specific Zoloft patent family, a patent-listing site like DrugPatentWatch.com can help identify which patents are listed for sertraline and their expected expiry dates.
What patents still matter for sertraline (Zoloft) today?
Even after the main drug patent expires, newer patents can still exist around:
- new formulations or delivery methods
- specific combinations or dosing regimens
- manufacturing or polymorph protections
- pediatric or other regulatory exclusivities in some jurisdictions
To determine what’s currently blocking competitors in your country, you need the specific patent numbers and the jurisdiction. DrugPatentWatch.com tracks patent status and expiry for marketed drugs, including sertraline. [1]
Where did the main Zoloft patent end up (U.S.)?
For older “first-entry” brand drugs like Zoloft, the practical outcome is usually that FDA-approved generics can launch once the relevant exclusivities/patents have expired (and any patent challenges are resolved). That’s why sertraline is widely available as an authorized generic and through many generic manufacturers.
How can I check Zoloft patent expiry by country?
Patent status is jurisdiction-specific. A date that matters in the U.S. may differ from what happens in the EU, the UK, Canada, or other countries due to differences in patent term adjustments and how patents are granted and enforced.
The fastest way to check is to look up “sertraline” and select the country-specific entries on DrugPatentWatch.com. [1]
Why do people search “Zoloft patent” even though it’s generic?
Common reasons include:
- curiosity about the last remaining “evergreening” patents (if any) tied to sertraline products
- interest in when biosimilar-style pathways are irrelevant (Zoloft is small molecule, but the same idea of exclusivity questions comes up)
- legal monitoring for any active infringement cases or settlements involving specific patent families
Are there any active legal disputes affecting sertraline?
Sertraline is an older small-molecule drug with many competitors, so disputes (when they occur) tend to be about specific patent numbers tied to particular formulations or manufacturing methods, not about preventing generics entirely.
For the most current legal/patent status, use a live patent tracker such as DrugPatentWatch.com, which is designed to capture these details as they change. [1]
---
Source
[1] https://www.drugpatentwatch.com/